Compare RLYB & MLGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RLYB | MLGO |
|---|---|---|
| Founded | 2018 | 2018 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.1M | 75.5M |
| IPO Year | 2021 | N/A |
| Metric | RLYB | MLGO |
|---|---|---|
| Price | $0.73 | $6.82 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 193.3K | 142.2K |
| Earning Date | 11-06-2025 | 12-16-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 4.04 |
| Revenue | $674,000.00 | ★ $61,302,336.00 |
| Revenue This Year | $17.61 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1.82 |
| Revenue Growth | ★ 12.71 | N/A |
| 52 Week Low | $0.22 | $6.00 |
| 52 Week High | $1.24 | $972.00 |
| Indicator | RLYB | MLGO |
|---|---|---|
| Relative Strength Index (RSI) | 64.63 | 44.88 |
| Support Level | $0.63 | $6.20 |
| Resistance Level | $0.80 | $7.45 |
| Average True Range (ATR) | 0.04 | 0.44 |
| MACD | 0.01 | 0.15 |
| Stochastic Oscillator | 67.74 | 52.80 |
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.
MicroAlgo Inc is divided into two segments: Central processing algorithm services & Intelligent chips and services. The majority is from the Central Processing Algorithm Services. which refers to a range of computing algorithms, analytical algorithms, recommendation algorithms, & acceleration algorithms. The businesses engaged in internet advertisement, game development, intelligent chip design, finance, retail, & logistics depend on the ability to process & analyze data with optimized computing software & hardware capable of handling the data workload. Intelligent chips and services revenues include revenues generated from the resale of intelligent chips. All of the Company's net revenues were generated in the PRC, Hong Kong, & Singapore, out of which the majority is from the PRC.